Seoul, July 2 (IANS) South Korea’s exports of pharmaceuticals surpassed $10 billion for the first time last year, while production of such products also climbed to a new record high, government data showed on Thursday.South Korean companies exported a total of $10.44 billion worth of pharmaceuticals in 2025, up 12.4 percent from a year earlier, according to the data from the Ministry of Food and Drug Safety, reports Yonhap news agency. Imports advanced 5.9 percent on-year to $8.93 billion.Trade …
Latest pharmaceutical exports News & Updates
New Delhi, June 9 (IANS) Commerce and Industry Minister Piyush Goyal said on Tuesday that India is well-positioned to serve the world as an innovator, manufacturer, reliable supplier of affordable medicines, partner in advanced healthcare technologies, and destination for contract manufacturing.Addressing the Global Ambassador Meet on the Pharmaceutical Sector here, the minister noted that Indian medicines are widely accepted across global markets owing to the industry’s established quality st…
Canberra, April 3 (IANS) The Australian federal government will not make changes to its subsidization scheme for medications amid tariff pressure from the US administration, said Mark Butler, the health minister, on Friday.Butler told Seven Network television that Australia will not negotiate with the United States on the “fundamentals” of the Pharmaceutical Benefits Scheme (PBS), under which the federal government subsidizes the cost of prescription medicines, Xinhua news agency reported.”We ke…
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Washington, Feb 20 (IANS) Two top American Senators have written to the Department of War Secretary Pete Hegseth seeking details on vulnerabilities in America’s pharmaceutical supply chain, warning that heavy reliance on foreign sources — particularly Communist China and India — could threaten military readiness and national security.The letter, sent by the US Senate Special Committee on Aging Chairman Rick Scott and Ranking Member Kirsten Gillibrand, asks the Department to outline how it …